WealthCare Investment Partners LLC Raises Position in iShares Biotechnology ETF (NASDAQ:IBB)

WealthCare Investment Partners LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,043 shares of the financial services provider’s stock after buying an additional 343 shares during the quarter. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,261,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IBB. Moneta Group Investment Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 131,598.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock worth $586,846,000 after acquiring an additional 4,466,451 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of iShares Biotechnology ETF by 159.9% in the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock valued at $253,975,000 after purchasing an additional 1,209,700 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in iShares Biotechnology ETF by 49.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after purchasing an additional 521,820 shares in the last quarter. Jane Street Group LLC increased its holdings in iShares Biotechnology ETF by 5.4% in the fourth quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock valued at $131,625,000 after buying an additional 50,999 shares during the last quarter. Finally, Itau Unibanco Holding S.A. acquired a new stake in iShares Biotechnology ETF during the third quarter valued at approximately $48,242,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.4 %

Shares of NASDAQ:IBB traded up $1.92 during trading on Wednesday, hitting $137.79. 1,273,966 shares of the company traded hands, compared to its average volume of 1,875,242. The business’s fifty day moving average is $136.37 and its 200-day moving average is $128.69. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 27th. Investors of record on Friday, March 22nd will be given a $0.126 dividend. The ex-dividend date is Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.